Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells
- PMID: 1518840
- PMCID: PMC49874
- DOI: 10.1073/pnas.89.17.8150
Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells
Abstract
We have investigated the regulation of the expression of two growth factors found in vascular smooth muscle, transforming growth factor alpha (TGF alpha) and basic fibroblast growth factor (bFGF). Cells cultured in medium containing 30 mM glucose exhibited a 2-fold increase in TGF alpha mRNA and a 3-fold increase in bFGF mRNA compared with cells grown in normal (5.5 mM) glucose. Glucosamine was more potent than glucose, leading to a 6-fold increase in TGF alpha mRNA. TGF alpha protein levels were also increased by glucosamine treatment, and the predominant species present was the membrane-bound precursor form of TGF alpha. To examine further the regulation of growth factors by sugars, cultured rat aortic smooth muscle cells were transfected with a plasmid construct consisting of a 1.2-kilobase-pair fragment of the TGF alpha promoter linked to a luciferase reporter gene. Increasing the concentration of glucose in the culture medium from 5.5 mM to 30 mM led to a rapid, 1.7-fold increase in the activity of the TGF alpha promoter. Glucosamine was much more potent than glucose in this stimulation, with 2 mM glucosamine causing a 12-fold increase in TGF alpha promoter activity. Insulin had no effect on luciferase activity in either the presence or the absence of added sugars. The glucose response element of the TGF alpha gene maps to a 130-base-pair segment that includes three potential binding sites for the transcription factor Sp1. We conclude that high glucose concentrations such as are reached in diabetes mellitus can stimulate the transcription of the genes for growth factors in vascular smooth muscle cells. This signaling pathway apparently involves the metabolism of glucose to glucosamine. This effect could be representative of nutritional regulation of a family of genes and could contribute to the toxicity of hyperglycemia and the vascular complications of diabetes.
Similar articles
-
Glucose regulation of transforming growth factor-alpha expression is mediated by products of the hexosamine biosynthesis pathway.Mol Endocrinol. 1993 Aug;7(8):1041-8. doi: 10.1210/mend.7.8.8232303. Mol Endocrinol. 1993. PMID: 8232303
-
Transcriptional regulation of transforming growth factor beta1 by glucose: investigation into the role of the hexosamine biosynthesis pathway.Am J Med Sci. 2000 Mar;319(3):138-42. doi: 10.1097/00000441-200003000-00002. Am J Med Sci. 2000. PMID: 10746823
-
Basic fibroblast growth factor antagonizes transforming growth factor-beta1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation.Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1384-90. doi: 10.1161/01.ATV.0000136548.17816.07. Epub 2004 Jun 24. Arterioscler Thromb Vasc Biol. 2004. PMID: 15217807
-
Transcriptional Regulation of Transforming Growth Factor β1 by Glucose: Investigation into the Role of the Hexosamine Biosynthesis Pathway.Am J Med Sci. 2020 Feb;359(2):79-83. doi: 10.1016/j.amjms.2019.12.013. Am J Med Sci. 2020. PMID: 32039769
-
Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells.Diabetes. 2000 May;49(5):863-71. doi: 10.2337/diabetes.49.5.863. Diabetes. 2000. PMID: 10905498
Cited by
-
TRIB3 mediates glucose-induced insulin resistance via a mechanism that requires the hexosamine biosynthetic pathway.Diabetes. 2013 Dec;62(12):4192-200. doi: 10.2337/db13-0312. Epub 2013 Aug 29. Diabetes. 2013. PMID: 23990361 Free PMC article.
-
TGF-β and Diabetic Nephropathy: Lessons Learned Over the Past 20 Years.Am J Med Sci. 2020 Feb;359(2):70-72. doi: 10.1016/j.amjms.2019.11.010. Epub 2019 Nov 29. Am J Med Sci. 2020. PMID: 32039767 Free PMC article. No abstract available.
-
Alterations of glomerular matrix proteins in the pathogenesis of diabetic nephropathy.Clin Investig. 1993;71(5 Suppl):S13-9. doi: 10.1007/BF00180071. Clin Investig. 1993. PMID: 8518535 Review.
-
Role of glucosamine in development of diabetic neuropathy independent of the aldose reductase pathway.Brain Commun. 2020 Oct 9;2(2):fcaa168. doi: 10.1093/braincomms/fcaa168. eCollection 2020. Brain Commun. 2020. PMID: 33305258 Free PMC article.
-
Responsiveness of the state of O-linked N-acetylglucosamine modification of nuclear pore protein p62 to the extracellular glucose concentration.Biochem J. 2000 Aug 15;350 Pt 1(Pt 1):109-14. Biochem J. 2000. PMID: 10926833 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources